VC firm

InFocus Capital Partners

Kingmaker Tier

Kingmaker Tier: 82 out of 100

Biotech & therapeutics
Care delivery & digital health
Health IT
Medical devices & diagnostics
Mental health & wellness
Women's & family health
VC
B2B

Investor type: VC

infocuscapitalpartners.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 21 September 2026

About

InFocus Capital Partners specializes in the identification, capitalization and development of breakthrough and disruptive opportunities in life sciences with an ophthalmic focus.

Investment approach

Thesis: The Fund’s experience, partnership structure and coverage of ophthalmic innovations yield a differentiated investment opportunity – optimizing the probability for successful returns.Source (opens in a new tab)
Takes board seats: Yes
Board policy: Member of the Board of Directors for Alievio, Cellview Imaging, Galimedix and QURA, Inc.

Portfolio companies in this preview

2C Tech Corporation, Inc.
Cellview Imaging
Galimedix
IACTA Pharma
Mojo
ONL Therapeutics, Inc.
Pr3vent
QURA, Inc.
and more in the full map

VC firm
Company
Partner

Company names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.

InFocus Capital Partners

About

Investment approach

Relationship map preview

Relationship map preview